Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion type Assertion NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_head.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion description "[Dukes stages C and D were more frequent in primary tumors with loss of MSH3 expression (9 of 13), compared with tumors with retained expression (1 of 14; Fisher's exact test, P = 0.001), suggesting that MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_provenance.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion evidence source_evidence_literature NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_provenance.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion SIO_000772 14871813 NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_provenance.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion wasDerivedFrom befree-20150227 NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_provenance.
- NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_assertion wasGeneratedBy ECO_0000203 NP570547.RAYYKBibMafRuKeI_doiJ8R4L0SeGxRBYo5MyZqem8Qak130_provenance.